AMRI to Present at Jefferies 3rd Annual Healthcare Conference

AMRI (NASDAQ: AMRI) announced today that it will present and provide an audio webcast of its corporate presentation at the Jefferies 3^rd Annual Healthcare Conference in New York City on Wednesday, June 17, 2009.

AMRI Senior Vice President, Administration and Chief Financial Officer Mark T. Frost will present in a session scheduled for 1:00 p.m. EDT. The audio webcast will be available to investors and interested parties by accessing the company’s website at www.amriglobal.com. In addition, a replay of the webcast will be available three minutes after the live webcast through September 17, 2009.

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.